Exela Pharma Sciences LLC recalls .2% Sodium Bicarbonate Injection
- Published
- 17 Sept 2025
- Units affected
- N/A
- Agency
- FDA
- Country
- United States
The hazard
Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton)
- Brand / company
- Exela Pharma Sciences LLC
- Codes / lots
- Lot # 10004077, Exp. 02/28/2026
- Distribution
- Nationwide in the USA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 17 Sept 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.